Skip to main content
Erschienen in: Breast Cancer Research and Treatment 1/2014

01.08.2014 | Epidemiology

Trends in breast cancer incidence and mortality in France 1990–2008

verfasst von: F. Molinié, A. Vanier, A. S. Woronoff, A. V. Guizard, P. Delafosse, M. Velten, L. Daubisse-Marliac, P. Arveux, B. Tretarre

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

The objective of this work was to detail the incidence and mortality trends of invasive and in situ breast cancer (BC) in France, especially regarding the development of screening, over the 1990–2008 period. Data issued from nine population-based cancer registries were studied. The incidence of invasive BC increased annually by 0.8 % from 1990 to 1996 and more markedly by 3.2 % from 1996 to 2003, and then sharply decreased until 2006 (−2.3 % per year), especially among women aged 50–69 years (−4.9 % per year). This trend was similar whatever the introduction date of the organized screening (OS) program in the different areas. The incidence of ductal carcinoma in situ steadily increased between 1990 and 2005, particularly among women aged 50–69 years and 70 and older. At the same time, the mortality from BC decreased annually by 1.1 % over the entire study period. This decrease was more pronounced in women aged 40–49 and 50–69 and, during the 1990–1999 period, in the areas where OS began in 1989–1991. The similarity in the incidence trends for all periods of implementation of OS in the different areas was striking. This suggests that OS alone does not explain the changes observed in incidence rate. Our study highlights the importance of closely monitoring the changes in incidence and mortality indicators, and of better understanding the factors causing variation.
Literatur
2.
Zurück zum Zitat Glass AG, Lacey JV Jr, Carreon JD, Hoover RN (2007) Breast cancer incidence, 1980–2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst 99:1152–1161. doi:10.1093/jnci/djm059 CrossRefPubMed Glass AG, Lacey JV Jr, Carreon JD, Hoover RN (2007) Breast cancer incidence, 1980–2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst 99:1152–1161. doi:10.​1093/​jnci/​djm059 CrossRefPubMed
3.
Zurück zum Zitat Weedon-Fekjær H, Bakken K, Vatten LJ, Tretli S (2012) Understanding recent trends in incidence of invasive breast cancer in Norway: age-period-cohort analysis based on registry data on mammography screening and hormone treatment use. BMJ 344:e299CrossRefPubMedCentralPubMed Weedon-Fekjær H, Bakken K, Vatten LJ, Tretli S (2012) Understanding recent trends in incidence of invasive breast cancer in Norway: age-period-cohort analysis based on registry data on mammography screening and hormone treatment use. BMJ 344:e299CrossRefPubMedCentralPubMed
6.
7.
Zurück zum Zitat European Network of Cancer Registries, Tyczyński JE, Démaret E, et al (2003) Standards and guidelines for cancer registration in Europe: the ENCR recommendations: volume I. International Agency for Research on Cancer, Lyon European Network of Cancer Registries, Tyczyński JE, Démaret E, et al (2003) Standards and guidelines for cancer registration in Europe: the ENCR recommendations: volume I. International Agency for Research on Cancer, Lyon
8.
Zurück zum Zitat R Development Core Team (2010) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna R Development Core Team (2010) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna
10.
Zurück zum Zitat Lacour A, Mamelle N, Arnold F et al (1997) Mass screening programs for breast cancer in France. Comparative evaluation. J Gynécologie Obstétrique Biol Reprod 26:470–483 Lacour A, Mamelle N, Arnold F et al (1997) Mass screening programs for breast cancer in France. Comparative evaluation. J Gynécologie Obstétrique Biol Reprod 26:470–483
15.
Zurück zum Zitat Daubisse-Marliac L, Delafosse P, Boitard JB et al (2011) Breast cancer incidence and time trend in France from 1990 to 2007: a population-based study from two French cancer registries. Ann Oncol 22:329–334. doi:10.1093/annonc/mdq396 CrossRefPubMed Daubisse-Marliac L, Delafosse P, Boitard JB et al (2011) Breast cancer incidence and time trend in France from 1990 to 2007: a population-based study from two French cancer registries. Ann Oncol 22:329–334. doi:10.​1093/​annonc/​mdq396 CrossRefPubMed
17.
20.
Zurück zum Zitat Séradour B, Allemand H, Weill A, Ricordeau P (2009) Changes by age in breast cancer incidence, mammography screening and hormone therapy use in France from 2000 to 2006. Bull Cancer 96:E1–E6. doi:10.1684/bdc.2009.0869 PubMed Séradour B, Allemand H, Weill A, Ricordeau P (2009) Changes by age in breast cancer incidence, mammography screening and hormone therapy use in France from 2000 to 2006. Bull Cancer 96:E1–E6. doi:10.​1684/​bdc.​2009.​0869 PubMed
21.
Zurück zum Zitat Dietel M, Lewis MA, Shapiro S (2005) Hormone replacement therapy: pathobiological aspects of hormone-sensitive cancers in women relevant to epidemiological studies on HRT: a mini-review. Hum Reprod (Oxford, England) 20:2052–2060. doi:10.1093/humrep/dei043 CrossRef Dietel M, Lewis MA, Shapiro S (2005) Hormone replacement therapy: pathobiological aspects of hormone-sensitive cancers in women relevant to epidemiological studies on HRT: a mini-review. Hum Reprod (Oxford, England) 20:2052–2060. doi:10.​1093/​humrep/​dei043 CrossRef
33.
Zurück zum Zitat Blanks RG, Moss SM, McGahan CE et al (2000) Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990–8: comparison of observed with predicted mortality. BMJ 321:665–669CrossRefPubMedCentralPubMed Blanks RG, Moss SM, McGahan CE et al (2000) Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990–8: comparison of observed with predicted mortality. BMJ 321:665–669CrossRefPubMedCentralPubMed
40.
Zurück zum Zitat Mandelblatt J, Schechter CB, Lawrence W, et al (2006) The SPECTRUM population model of the impact of screening and treatment on U.S. breast cancer trends from 1975 to 2000: principles and practice of the model methods. J Natl Cancer Inst Monogr (36):47–55. doi:10.1093/jncimonographs/lgj008 Mandelblatt J, Schechter CB, Lawrence W, et al (2006) The SPECTRUM population model of the impact of screening and treatment on U.S. breast cancer trends from 1975 to 2000: principles and practice of the model methods. J Natl Cancer Inst Monogr (36):47–55. doi:10.​1093/​jncimonographs/​lgj008
44.
Zurück zum Zitat Ringa V, Fournier A (2008) Did the decrease in use of menopausal hormone therapy induce a decrease in the incidence of breast cancer in France (and elsewhere)? Rev Epidémiologie Santé Publique 56:297–301. doi:10.1016/j.respe.2008.07.085 CrossRef Ringa V, Fournier A (2008) Did the decrease in use of menopausal hormone therapy induce a decrease in the incidence of breast cancer in France (and elsewhere)? Rev Epidémiologie Santé Publique 56:297–301. doi:10.​1016/​j.​respe.​2008.​07.​085 CrossRef
Metadaten
Titel
Trends in breast cancer incidence and mortality in France 1990–2008
verfasst von
F. Molinié
A. Vanier
A. S. Woronoff
A. V. Guizard
P. Delafosse
M. Velten
L. Daubisse-Marliac
P. Arveux
B. Tretarre
Publikationsdatum
01.08.2014
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 1/2014
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-014-3073-9

Weitere Artikel der Ausgabe 1/2014

Breast Cancer Research and Treatment 1/2014 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.